| Index | — | P/E | 36.99 | EPS (ttm) | 2.25 | Insider Own | 41.64% | Shs Outstand | 50.52M | Perf Week | -1.61% |
| Market Cap | 4.20B | Forward P/E | — | EPS next Y | — | Insider Trans | -1.31% | Shs Float | 30.86M | Perf Month | 10.28% |
| Enterprise Value | 3.97B | PEG | — | EPS next Q | — | Short Float | 3.97% | Perf Quarter | 40.83% | ||
| Income | 115.00M | P/S | 4.27 | EPS this Y | — | Short Ratio | 6.40 | Perf Half Y | 45.35% | ||
| Sales | 985.00M | P/B | 10.28 | EPS next Y | — | ROA | 16.72% | Short Interest | 1.23M | Perf YTD | 22.99% |
| Book/sh | 8.10 | P/C | 16.42 | EPS next 5Y | — | ROE | 29.93% | 52W High | 85.15 -2.25% | Perf Year | 13.07% |
| Cash/sh | 5.07 | P/FCF | 37.21 | EPS past 3/5Y | 19.31% -3.06% | ROIC | 26.38% | 52W Low | 44.83 85.66% | Perf 3Y | 30.47% |
| Dividend Est. | — | EV/EBITDA | 21.57 | Sales past 3/5Y | 10.08% 11.64% | Gross Margin | 23.90% | Volatility | 2.25% 2.44% | Perf 5Y | 43.87% |
| Dividend TTM | — | EV/Sales | 4.03 | EPS Y/Y TTM | 15.98% | Oper. Margin | 15.37% | ATR (14) | 1.99 | Perf 10Y | 621.86% |
| Dividend Ex-Date | — | Quick Ratio | 1.94 | Sales Y/Y TTM | 7.18% | Profit Margin | 11.72% | RSI (14) | 68.64 | Recom | — |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.94 | EPS Q/Q | 21.15% | SMA20 | 3.46% | Beta | 1.06 | Target Price | — |
| Payout | 0.00% | Debt/Eq | 0.05 | Sales Q/Q | 10.64% | SMA50 | 11.02% | Rel Volume | 0.93 | Prev Close | 82.22 |
| Employees | 5,239 | LT Debt/Eq | 0.05 | Earnings | Nov 03 | SMA200 | 33.06% | Avg Volume | 185.79K | Price | 83.23 |
| IPO Date | Jun 28, 1991 | Option/Short | Yes / Yes | EPS/Sales Surpr. | — | Net Debt/EBITDA | -1.28 | Volume | 171,993 | Change | 1.23% |
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2026 3/31/2026 | FY 2025 3/31/2025 | FY 2024 3/31/2024 | FY 2023 3/31/2023 | FY 2022 3/31/2022 | FY 2021 3/31/2021 | FY 2020 3/31/2020 | FY 2019 3/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 985 | 959 | 896 | 795 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 749 | 726 | 686 | 624 | — | — | — | — | — | |
| Gross Profit | 235 | 233 | 210 | 172 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 89,712 | 89,732 | 89 | 77 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -89,628 | -89,642 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 151 | 143 | 121 | 95 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | 151 | 143 | 121 | 95 | — | — | — | — | — | |
| Income Taxes | 36 | 33 | 26 | 19 | — | — | — | — | — | |
| Consolidated Net Income | 115 | 110 | 95 | 76 | — | — | — | — | — | |
| Net Income From Continuing Operations | 115 | 110 | 95 | 76 | — | — | — | — | — | |
| Net Income | 115 | 110 | 95 | 76 | — | — | — | — | — | |
| EPS (Recurring) | 2.25 | 2.15 | 1.85 | 1.48 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 2.25 | 2.15 | 1.85 | 1.48 | — | — | — | — | — | |
| EPS (Diluted) | 2.25 | 2.14 | 1.83 | 1.47 | — | — | — | — | — | |
| EBITDA | 184 | 175 | 150 | 121 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 36.99 | 25.54 | 61.19 | 59.63 | — | — | — | — | — | |
| Price To Sales Ratio | 4.31 | 2.91 | 6.37 | 5.62 | — | — | — | — | — | |
| Gross Margin | 23.86 | 24.30 | 23.44 | 21.64 | — | — | — | — | — | |
| Operating Margin | 15.33 | 14.91 | 13.50 | 11.95 | — | — | — | — | — | |
| Net Margin | 11.68 | 11.47 | 10.60 | 9.56 | — | — | — | — | — | |
| Shares Outstanding | 51 | 51 | 51 | 51 | — | — | — | — | — | |
| Market Capitalization | 4,245 | 2,787 | 5,710 | 4,470 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| CORSTAR HOLDINGS INC | 10% Owner | Sep 14 '26 | Sale | 70.16 | 127,824 | 8,968,055 | 18,517,108 | Sep 15 |
| CORSTAR HOLDINGS INC | 10% Owner | Sep 11 '26 | Sale | 69.05 | 30,925 | 2,135,303 | 18,644,932 | Sep 15 |
| CORSTAR HOLDINGS INC | 10% Owner | Sep 04 '26 | Sale | 68.76 | 14,538 | 999,573 | 18,675,857 | Sep 08 |
| CORSTAR HOLDINGS INC | 10% Owner | Sep 03 '26 | Sale | 68.91 | 51,713 | 3,563,605 | 18,690,395 | Sep 08 |
| JESSUP R JUDD | Director | Sep 01 '26 | Sale | 70.07 | 4,023 | 281,892 | 111,798 | Sep 03 |
| JESSUP R JUDD | Director | Aug 27 '26 | Sale | 70.64 | 1,262 | 89,148 | 115,821 | Aug 28 |
| JESSUP R JUDD | Director | Aug 26 '26 | Sale | 70.71 | 1,562 | 110,449 | 117,083 | Aug 28 |
| Yoss Jennifer | Vice President of Accounting | Aug 20 '26 | Option Exercise | 65.72 | 2,100 | 138,012 | 4,273 | Aug 24 |
| Yoss Jennifer | Vice President of Accounting | Aug 20 '26 | Sale | 70.92 | 2,100 | 148,922 | 2,173 | Aug 24 |
| Nichols Brian S. | Chief Financial Officer | Aug 04 '26 | Option Exercise | 52.65 | 51 | 2,685 | 56 | Aug 05 |
| HOOPS ALAN | Director | Jul 31 '26 | Option Exercise | 14.44 | 9,000 | 129,960 | 33,192 | Aug 03 |
| Bertels Mark E. | EVP - Risk Management Services | Jul 29 '26 | Option Exercise | 52.65 | 750 | 39,485 | 3,576 | Jul 30 |
| Combs Michael G | CEO & President | Jun 12 '26 | Sale | 60.79 | 500 | 30,395 | 12,322 | Jun 15 |
| Shishin Maxim | Chief Information Officer | Jun 12 '26 | Option Exercise | 52.65 | 2,250 | 118,456 | 9,300 | Jun 15 |
| Shishin Maxim | Chief Information Officer | Jun 12 '26 | Sale | 60.59 | 2,250 | 136,328 | 7,050 | Jun 15 |